Day Three
Program
Day 3: Wednesday, October 24, 2018
Session F – Viruses, the Emerging Global Health Challenge
Improving health and achieving equity in health for all people worldwide is to understand that viruses know no national border and have a far reaching global impact. Identifying trends and challenges in emerging viral diseases that pose a threat to global health is critical. Advances in technology and rapid discovery methods and treatment lend a helping hand but there is still a measurable amount of work to be done. This session aims to provide more detail on the preparedness and response to those emerging viral threats through the development of novel scientific concepts.
Chairpersons and Discussants:
Christian Brechot, MD, PhD, Global Virus Network, US
Alan Schmaljohn, PhD, University of Maryland School of Midicine, US
Schedule:
9:00 AM
Opening Remarks
Christian Brechot, MD PhD, Global Virus Network, US
9:10 AM
Presentation Title: A hemagglutinin stalk-based universal influenza virus vaccine
Speaker: Florian Krammer, PhD, Icahn School of Medicine at Mount Sinai, US
9:35 AM
Presentation Title: Antivirals, a lot has been achieved, yet a long way to go
Speaker: Johan Neyts, PhD, Rega Institute, Belgium
10:00 AM
Presentation Title: Catching Chances: The Movement to Be on the Ground and Research Ready Before an Outbreak
Speaker: David Brett-Major, MD, MPH, Uniformed Services University
Coffee Break, 10:25 AM - 10:45 AM
10:45 AM
Presentation Title: TBA
Speaker: TBA
11:10 AM
Presentation Title: Surveillance of viral zoonoses in Africa
Speaker: Aaron Mweene, PhD, University of Zambia, Zambia
11:35 AM
Presentation Title: Ebola and Lassa fever: Lessons learned, continuing challenges
Speaker: Robert Garry, PhD, Tulane University School of Medicine, US
Lunch Break, 11:50 AM - 1:10 PM
Session G – PEPFAR: Towards HIV Epidemic Control
The US Presidents Emergency Plan for AIDS Relief (PEPFAR) marks its 15th Anniversary this year. PEPFAR had been the world’s leader in responding to the global HIV/AIDS crisis since 2003, when President George W. Bush initiated the program. PEPFAR has enhanced health security worldwide by delivering antiretroviral therapy to more than 13.3 million men, women and children; voluntary medical male circumcision to more than 15.2 million men to reduce the risk of HIV; prenatal care that led to the prevention of 2.2 million perinatal HIV infections; and support for more than 6.4 million orphans and other vulnerable children impacted by HIV. Despite strides in controlling this worldwide epidemic, there is still a need for programs designed to advance the strengthening of global capacity to prevent, detect, and respond to HIV and other infectious disease threats.
Chairpersons and Discussants:
Manhattan Charurat, PhD, Institute of Human Virology, University of Maryland School of Medicine, US
Anthony Amoroso, MD, Institute of Human Virology, University of Maryland School of Medicine, US
Schedule:
1:10 PM
Presentation Title: Special Lecture: PEPFAR- challenges and opportunities
Speaker: Mark Dybul, MD, Georgetown University, US
1:40 PM
Presentation Title: Special Lecture: TBA
Speaker: Permanent Secretary Jabbin Mulwanda, Health Services, Zambia
2:10 PM
Presentation Title: PEPFAR: Research Findings and Gaps Remaining
Speaker: Laura Guay, MD, George Washignton University, Elizabeth Glazer Pediatric AIDS Foundation, US
2:35 PM
Presentation Title: TBA
Speaker: Scott Geibel, PhD, MPH, Population Council, US
3:00 PM
Presentation Title: Academic institutional impact on global HIV pandemic response: A decade of Implementing PEPFAR programs by University of Maryland Baltimore
Speaker: Deus Bazira, DrPH, Institute of Human Virology, University of Maryland School of Medicine, US
Coffee Break, 3:25 PM - 3:45 PM
Session H – Lifetime Achievement Award Mini-Symposium
The 2018 IHV Lifetime Achievement Award for Medical Education, Clinical Care and Clinical Research is given to Dr. Henry Masur, who recognized some of the first patients with HIV infection and initiated a program in New York that described the emerging manifestation of AIDS. He later joined the NIH Clinical Center, initiating the first NIH sponsored guideline related to AIDS management. This special symposium is, in part, dedicated to his work and features presentations by Richard Whitley, MD, University of Alabama at Birmingham, and Clifford Lane, MD, National Institute of Allergy and Infectious Diseases.
The IHV Lifetime Achievement Award for Excellence in Clinical Research this year is given to Dr. Kiyoshi Takatsuki, whose seminal discovery of Adult T-cell leukemia (ATL) led to the discovery of the first human oncogenic retrovirus, HTLV-1. His group’s subsequent HTLV-1 research unveiled the three routes of transmission of the disease. Masao Matsuoka, MD, PhD and Junji Yodoi, PhD, both from Kyoto University in Japan, will present honorary lectures on behalf of Dr. Takatsuki in this special symposium.
Chairpersons and Discussants:
John Martin, PhD, Gilead Sciences, Inc., US
William Blattner, MD, Salt Run Global, US
Schedule:
3:45 PM
Opening Remarks
Robert Gallo, MD, Institute of Human Virology, University of Maryland School of Medicine, US
3:55 PM
Presentation Title: Speaking in Honor of Henry Masur: The Development of Oncolytic Herpes Simplex Viruses for the Treatment of Glioblastoma Multiforme
Speaker: Richard Whitley, MD, University of Alabama at Birmingham, US
4:25 PM
Presentation Title: Speaking in honor of Henry Masur: The Potential Role of "Defective" Proviruses in the Pathogenesis of HIV-1 Infection
Speaker: H. Clifford Lane, MD, National Instiutute of Allergy and Infectious Diseases, US
4:55 PM
Presentation Title: Speaking in honor of Kiyoshi Takatsuki: Clinical landscape of adult T-cell leukemia: its impacts on hematology, virology, and immunology
Speaker: Masao Matsuoka, MD, PhD, Kyoto University, Japan
5:25 PM
Presentation Title: Speaking in honor of Kiyoshi Takatsuki: ATL, ADF and Human Virus Research
Speaker: Junji Yodoi, MD, PhD, Kyoto University, Japan
Gala Reception 6:30 PM / 7:15 PM Lifetime Achievement Award Dinner